My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 217

    1.

    Evaluation of recombinant invasive, non-pathogenic Eschericia coli as a vaccine vector against the intracellular pathogen, Brucella.

    Harms JS, Durward MA, Magnani DM, Splitter GA.

    J Immune Based Ther Vaccines. 2009 Jan 6;7:1.PMID: 19126207 [PubMed - in process]Related articlesFree article

    2.

    Induction of antigen-specific Th1-type immune responses by gamma-irradiated recombinant Brucella abortus RB51.

    Sanakkayala N, Sokolovska A, Gulani J, Hogenesch H, Sriranganathan N, Boyle SM, Schurig GG, Vemulapalli R.

    Clin Diagn Lab Immunol. 2005 Dec;12(12):1429-36.PMID: 16339067 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Nondividing but metabolically active gamma-irradiated Brucella melitensis is protective against virulent B. melitensis challenge in mice.

    Magnani DM, Harms JS, Durward MA, Splitter GA.

    Infect Immun. 2009 Nov;77(11):5181-9. Epub 2009 Aug 24.PMID: 19703982 [PubMed - indexed for MEDLINE]Related articles

    4.

    Liposomised recombinant ribosomal L7/L12 protein protects BALB/c mice against Brucella abortus 544 infection.

    Mallick AI, Singha H, Chaudhuri P, Nadeem A, Khan SA, Dar KA, Owais M.

    Vaccine. 2007 May 4;25(18):3692-704. Epub 2007 Jan 25.PMID: 17296251 [PubMed - indexed for MEDLINE]Related articles

    5.

    Escheriosome-mediated delivery of recombinant ribosomal L7/L12 protein confers protection against murine brucellosis.

    Mallick AI, Singha H, Khan S, Anwar T, Ansari MA, Khalid R, Chaudhuri P, Owais M.

    Vaccine. 2007 Nov 14;25(46):7873-84. Epub 2007 Sep 20.PMID: 17931756 [PubMed - indexed for MEDLINE]Related articles

    7.

    Killing of Brucella antigen-sensitized macrophages by T lymphocytes in bovine brucellosis.

    Wyckoff JH 3rd, Potts RD.

    Vet Immunol Immunopathol. 2007 Dec 15;120(3-4):148-59. Epub 2007 Aug 11.PMID: 17904229 [PubMed - indexed for MEDLINE]Related articles

    8.

    Expanding the repertoire of Modified Vaccinia Ankara-based vaccine vectors via genetic complementation strategies.

    Garber DA, O'Mara LA, Zhao J, Gangadhara S, An I, Feinberg MB.

    PLoS One. 2009;4(5):e5445. Epub 2009 May 6.PMID: 19421328 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Protection of mice from Brucella infection by immunization with attenuated Salmonella enterica serovar typhimurium expressing A L7/L12 and BLS fusion antigen of Brucella.

    Zhao Z, Li M, Luo D, Xing L, Wu S, Duan Y, Yang P, Wang X.

    Vaccine. 2009 Aug 20;27(38):5214-9. Epub 2009 Jul 9.PMID: 19596411 [PubMed - indexed for MEDLINE]Related articles

    10.

    Molecular and cellular interactions between Brucella abortus antigens and host immune responses.

    Oliveira SC, Soeurt N, Splitter G.

    Vet Microbiol. 2002 Dec 20;90(1-4):417-24. Review.PMID: 12414160 [PubMed - indexed for MEDLINE]Related articles

    11.

    A killed, genetically engineered derivative of a wild-type extraintestinal pathogenic E. coli strain is a vaccine candidate.

    Russo TA, Beanan JM, Olson R, Genagon SA, MacDonald U, Cope JJ, Davidson BA, Johnston B, Johnson JR.

    Vaccine. 2007 May 10;25(19):3859-70. Epub 2007 Feb 5.PMID: 17306426 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Mucosal vaccine using CTL epitope-pulsed dendritic cell confers protection for intracellular pathogen.

    Ozawa Y, Suda T, Nagata T, Hashimoto D, Nakamura Y, Enomoto N, Inui N, Koide Y, Nakamura H, Chida K.

    Am J Respir Cell Mol Biol. 2009 Oct;41(4):440-8. Epub 2009 Feb 6.PMID: 19202004 [PubMed - indexed for MEDLINE]Related articles

    13.

    Listeria-based anti-infective vaccine strategies.

    Liu D.

    Recent Pat Antiinfect Drug Discov. 2006 Nov;1(3):281-90. Review.PMID: 18221153 [PubMed - indexed for MEDLINE]Related articles

    14.

    Attenuated recombinant Yersinia as live oral vaccine carrier to protect against amoebiasis.

    Lotter H, Rüssmann H, Heesemann J, Tannich E.

    Int J Med Microbiol. 2008 Jan;298(1-2):79-86. Epub 2007 Sep 27. Review.PMID: 17900982 [PubMed - indexed for MEDLINE]Related articles

    15.

    Progress towards the use of Listeria monocytogenes as a live bacterial vaccine vector for the delivery of HIV antigens.

    Paterson Y, Johnson RS.

    Expert Rev Vaccines. 2004 Aug;3(4 Suppl):S119-34. Review.PMID: 15285711 [PubMed - indexed for MEDLINE]Related articles

    16.

    Development of a tripartite vector system for live oral immunization using a gram-negative probiotic carrier.

    Buddenborg C, Daudel D, Liebrecht S, Greune L, Humberg V, Schmidt MA.

    Int J Med Microbiol. 2008 Jan;298(1-2):105-14. Epub 2007 Oct 23. Review.PMID: 17936683 [PubMed - indexed for MEDLINE]Related articles

    17.

    High efficacy of a Listeria-based vaccine against metastatic breast cancer reveals a dual mode of action.

    Kim SH, Castro F, Paterson Y, Gravekamp C.

    Cancer Res. 2009 Jul 15;69(14):5860-6. Epub 2009 Jul 7.PMID: 19584282 [PubMed - indexed for MEDLINE]Related articles

    18.

    An oral recombinant Salmonella enterica serovar Typhimurium mutant elicits systemic antigen-specific CD8+ T cell cytokine responses in mice.

    Chin'ombe N, Bourn WR, Williamson AL, Shephard EG.

    Gut Pathog. 2009 Apr 29;1(1):9.PMID: 19402893 [PubMed - in process]Related articlesFree article

    19.

    Capsular polysaccharide and the O-specific antigen impede antibody binding: a potential obstacle for the successful development of an extraintestinal pathogenic Escherichia coli vaccine.

    Russo TA, Beanan JM, Olson R, MacDonald U, Cope JJ.

    Vaccine. 2009 Jan 14;27(3):388-95. Epub 2008 Nov 17.PMID: 19014988 [PubMed - indexed for MEDLINE]Related articles

    20.

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk